36C24220A0011-000.docx

DOCX document Posted

Attached to
6640--BioFire Panels
Solicitation number
36C24220Q0380
Issued by

About this file

36C24220A0011 36C24220A0011_1.docx

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Contract Opportunity Special Notice

CLASSIFICATION CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

GENERAL INFORMATION

ADDITIONAL INFORMATION

* = Required Field Contract Opportunity Special Notice BioFire Panels 14227 36C24220Q0380 N 334516 Department of Veterans Affairs Network Contracting Office (NCO) 2 2875 Union Road Suite 3500 Cheektowaga NY 14227 Idalia Algarin idalia.algarin@va.gov 716-862-7461 x 22395 Notice of Intend to Award Sole Source

The Department of Veterans Affairs Administration, Network Contracting Office NC02, and The Molecular section of the Pathology & Laboratory Medicine Service for East Orange and Syracuse VA Medical Centers require BioFire Film Array Panels (reagents) to be use with the BioFire Film Array (Torch) instrument.

The BioFire Blood Culture ID panel (reagents) will allow East Orange and Syracuse VA Medical Centers to manage patients sooner and decrease inpatient length of stay. Quicker answers will lead to better patient satisfaction and reduced inpatient cost. Presently there is no other manufacturer that offers such extensive identification list for blood and respiratory pathogens as the BioFire Diagnostics technology. This request is for a blanket purchase agreement for base plus two (2) option years as the frequency of sepsis is unpredictable.

Justification for Sole Sources:

BioFire Diagnostics technology also meets the National Patient Safety Goals and Joint Commission requirements to reduce whole blood volume as much as possible on all lab testing. The BioFire Diagnostic Reagents are the only reagents that can be utilized on the BioFire Diagnostic FilmArray Analyzer which is used by the Pathology and Laboratory Medicine Departments. The Film Array Test Panels are an FDA approved closed PCR system for the detection of infectious agents. The Film Array instrument integrates sample preparation, amplification, detection, and analysis into one simple system that requires approximately two minutes hands on time and has a total run time of approximately one hour. The Film Array Blood Culture Panel tests for a comprehensive list of twenty-four pathogens and three antibiotic resistant genes associated with difficult to treat blood culture infections and high mortality rates. The results are available within one hour, providing fast and accurate information for successful patient treatment and timely patient discharge.

DETERMINATION:

Based on the above findings and in accordance with the cited authority, I hereby determine that it is not feasible or practical to invoke the competitive solicitation process under either Section 402 or 403 of the District of Columbia Procurement Practices Reform Act of 2010 (D.C. Law 18-371; D.C. Official Code § 2-354.02 or 2-354.03). Accordingly, I determine that the District is justified in using the sole source method of procurement.

Idalia Algarin______________________________03/10/2020______________
Idalia Algarin, CODate

Contracting Officer

File details come from the government source that posted it. Updated .